vikaschauhan 
The latest report by IMARC Group, titled “Artificial Cornea and Corneal Implant Market : Global Artificial Cornea and Corneal Implant Market Size, Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on artificial cornea and corneal implant market report. The report also includes competitor and regional analysis, and contemporary advancements in the global market. finds that the artificial cornea and corneal implant market size reached US$ 385.5 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 605 Million in 2027, expanding at a CAGR of around 7.10% during the forecast period (2022-2027).
Artificial cornea and corneal implant refer to the surgical materials used to replace parts of the damaged cornea with healthy corneal tissue using a wide range of surgical techniques. It is designed for long-term vision restoration and is performed to treat keratoconus, infectious keratitis, corneal ulcers, and Fuchs dystrophy diseases. The implants are commonly available in synthetic and biosynthetic variants, which are manufactured with polymer plastics and silica materials.
| Report Metric |
| Historical: 2016-2021 |
| Base Year: 2021 |
| Forecast Year: 2022-2027 |
Artificial Cornea and Corneal Implant Market Trends and Drivers:
The market is primarily driven by the increasing prevalence of corneal infections and eye-related disorders among individuals. Besides this, the rising geriatric population that is more susceptible to these ailments is also contributing to the market growth.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/artificial-cornea-corneal-implant-market/requestsample
In addition, the market is propelled by the increasing preference for penetrating keratoplasty procedures as these procedures involve full-thickness corneal transplantation, which aids in treating ecstatic corneal diseases. Apart from this, the rising number of artificial cornea and corneal implants to treat cloudy cornea caused by prolonged screen exposure represents another major growth-inducing factor.
Moreover, several key players are introducing innovative product variants, such as three-dimensional (3D) printed artificial corneas that offer enhanced biocompatibility and customizability. This, coupled with the significant improvement in the healthcare infrastructure and the implementation of various government initiatives, is anticipated to propel the market growth in the coming years.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Artificial Cornea and Corneal Implant Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the major key players operating in the market.
Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC and San Diego Eye Bank.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/artificial-cornea-corneal-implant-market
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial cornea and corneal implant market, along with forecasts at the global, regional and country level from 2022-2027.
The report has segmented the market on the basis of region, type, transplant type, disease indication and end user.
Breakup by Type:
- Human Cornea
- Artificial Cornea
Breakup by Transplant Type:
- Penetrating Keratoplasty
- Endothelial Keratoplasty
- Anterior Lamellar Keratoplasty
- Keratoprosthesis
Breakup by Disease Indication:
- Fuchs’ Dystrophy
- Fungal Keratitis
- Keratoconus
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=4961&flag=F
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Detailed Analysis Of the Global Market Share
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Latest Industry Trends And Developments
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Other Reports Of IMARC Group :
Population Health Management Market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
